Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
Introduction: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women. PCOS comprises a broad spectrum of anomalies, including hyperandrogenism, chronic anovulation, obesity, and infertility. Insulin resistance and its compensatory hyperinsulinemia play a key role in...
Main Authors: | Karoon Shahebrahimi, Nasrin Jalilian, Nasrin Bazgir, Mansour Rezaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=6;spage=805;epage=809;aulast=Shahebrahimi |
Similar Items
-
Effects of Pioglitazone and Metformin on Insulin Resistance Reduction in Polycystic Ovary Syndrome: A Comparative Study
by: Amir Ziaie, et al.
Published: (2012-03-01) -
Clomiphene citrate alone, in combination with metformin or in combination with pioglitazone as first line therapy in induction of ovulation in infertile women with polycystic ovary syndrome, a randomized controlled trial
by: Wessam Magdi Abuelghar, et al.
Published: (2013-09-01) -
Long-term results of correction of metabolic disorders in polycystic ovary syndrome after metformin treatment
by: O.O. Korytko, et al.
Published: (2019-11-01) -
Effect of metformin on early pregnancy loss in women with polycystic ovary syndrome
by: Mawahib A.S. Al-Biate
Published: (2015-06-01) -
Combined pioglitazone–metformin and clomiphene citrate versus metformin and clomiphene citrate in induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome
by: Ghada Abdel Fattah, et al.
Published: (2014-03-01)